1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/66060
Full metadata record
DC FieldValueLanguage
dc.creatorTatiani Uceli Maiolipt_BR
dc.creatorLuísa Martins Trindadept_BR
dc.creatorAline Souzapt_BR
dc.creatorLícia Torrespt_BR
dc.creatorMaria Emília Rabelo Andradept_BR
dc.creatorValbert Nascimento Cardosopt_BR
dc.creatorSimone de Vasconcelos Generosopt_BR
dc.date.accessioned2024-03-19T14:33:50Z-
dc.date.available2024-03-19T14:33:50Z-
dc.date.issued2022-
dc.citation.volume145pt_BR
dc.identifier.doihttps://doi.org/10.1016/j.biopha.2021.112414pt_BR
dc.identifier.issn1950-6007pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/66060-
dc.description.resumoInflammatory bowel diseases, irritable bowel syndrome, and mucositis are characterized by intestinal inflammation, but vary according to their pathological mechanisms, severity, location, and etiology. Significant intestinal inflammation that occurs in these diseases induces weight loss, nutritional depletion, and gastrointestinal tract dysfunction. Nutritional support is important in alleviating symptoms and improving patients’ quality of life. In this review, we summarize some nutritional components used to manage intestinal disorders. These include fatty acids, probiotics, parabiotics, postbiotics, prebiotics, synbiotics, and low FODMAP (LFD) diets. These components and LFD diets have been studied and clinical trials have been designed to develop new strategies to alleviate intestinal inflammation and improve the quality of life. Clinical trials on their use in intestinal inflammation do not allow firm conclusions to be drawn mainly because of the heterogeneity of the dose used and the study design or their inconclusive results. However, in the majority of cases, the use of omega-3, probiotics, parabiotics, postbiotics, prebiotics, synbiotics, and LFD improve the health.pt_BR
dc.description.sponsorshipCNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológicopt_BR
dc.description.sponsorshipFAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Geraispt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentENF - DEPARTAMENTO DE NUTRIÇÃOpt_BR
dc.publisher.departmentFAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICASpt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofBiomedicine & Pharmacotherapypt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectIntestinal inflammationpt_BR
dc.subjectOmega-3pt_BR
dc.subjectProbioticpt_BR
dc.subjectPrebioticpt_BR
dc.subjectSynbioticpt_BR
dc.subjectFODMAPpt_BR
dc.subject.otherDoenças inflamatórias intestinaispt_BR
dc.subject.otherÁcidos graxos Ômega-3pt_BR
dc.subject.otherProbióticospt_BR
dc.subject.otherPrebióticospt_BR
dc.subject.otherSimbióticospt_BR
dc.subject.otherDieta FODMAPpt_BR
dc.titleNon-pharmacologic strategies for the management of intestinal inflammationpt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.sciencedirect.com/science/article/pii/S0753332221012002?via%3Dihubpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-7538-3208pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-7597-9602pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-6413-8031pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Non-pharmacologic strategies for the management of intestinal inflammation.pdf482.72 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.